1. Yes-Associated Protein Promotes the Development of Condyloma Acuminatum through EGFR Pathway Activation
   Zhenghui Yang et al, 2020, Dermatology CrossRef
2. Hippo signaling in cancer: regulatory mechanisms and therapeutic strategies
   Zhao Huang et al, 2023, Australian Journal of Chemistry CrossRef
3. Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
   Jiaxin Yong et al, 2021, Drug Design, Development and Therapy CrossRef
4. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
   Hirohito Yamaguchi et al, 2020, Frontiers in Oncology CrossRef
5. Effect of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7
   Chang-Jiang Lei et al, 2016, Asian Pacific Journal of Tropical Medicine CrossRef
6. The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma
   Jing Wei et al, 2019, Cancer Cell International CrossRef
7. YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells
   Xin Jin et al, 2017, Molecular Medicine Reports CrossRef
8. Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor
   Lara Diego-González et al, 2022, Cancers CrossRef
9. Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications
   Michela Saviana et al, 2021, Cancers CrossRef
10. The Hippo pathway as a drug target in gastric cancer
    Yiting Qiao et al, 2018, Cancer Letters CrossRef
11. Small extracellular vesicles: Multi-functional aspects in non-small cell lung carcinoma
    Hafiza Padinharayil et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
12. Plasminogen activator urokinase interacts with the fusion protein and antagonizes the growth of Peste des petits ruminants virus
    Junhuang Wu et al, 2024, Journal of Virology CrossRef
13. YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
    Stefano Piccolo et al, 2022, Nature Cancer CrossRef
14. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity
    Kai Yin et al, 2018, Biochemical and Biophysical Research Communications CrossRef
15. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery
    Mehrdad Hashemi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
16. The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
    Richard Drexler et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
17. Polyacetylene Isomers Isolated from Bidens pilosa L. Suppress the Metastasis of Gastric Cancer Cells by Inhibiting Wnt/β-Catenin and Hippo/YAP Signaling Pathways
    Jing Cai et al, 2023, Molecules CrossRef
18. YAP/TAZ Activation as a Target for Treating Metastatic Cancer
    Janine Warren et al, 2018, Cancers CrossRef
19. Protein phase separation in cell death and survival
    Michael C. Chung et al, 2022, Mechanisms of Cell Death and Opportunities for Therapeutic Development CrossRef
20. Dysregulation of the Hippo pathway signaling in aging and cancer
    Yiu To Yeung et al, 2019, Pharmacological Research CrossRef
21. New therapeutic options opened by the molecular classification of gastric cancer
    Mihaela Chivu-Economescu et al, 2018, World Journal of Gastroenterology CrossRef
22. siRNA-based therapy for gastric adenocarcinoma: what’s next step?
    Dyar Mudhafar Salman et al, 2024, Pathology - Research and Practice CrossRef
23. The roles of the Hippo pathway in cancer metastasis
    Helena J. Janse van Rensburg et al, 2016, Cellular Signalling CrossRef
24. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer
    Seong-Hun Kim et al, 2019, International Journal of Molecular Sciences CrossRef
25. Context-dependent roles of YAP/TAZ in stem cell fates and cancer
    Lucy LeBlanc et al, 2021, Cellular and Molecular Life Sciences CrossRef
26. Dual roles of yes-associated protein (YAP) in colorectal cancer
    Chunlin Ou et al, 2017, Oncotarget CrossRef